Use of N-Butyl Cyanoacrylate in Transarterial Emergency Embolization
NCT ID: NCT06301919
Last Updated: 2025-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
122 participants
OBSERVATIONAL
2024-03-01
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Its use requires a steep learning curve to control emulsification of the NBCA/lipiodol mixture, and injection, to avoid non-target embolization.
The aim of this retrospective monocentric study was to evaluate safety and efficacy of use of NBCA as embolic agent in emergency setting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Cyanoacrylate Glue on PICC Line Dressing Care
NCT05246709
Ethanol in the Prevention of Central Venous Catheter Infections
NCT01229592
Use of the Skin Glue in the Placement of Central Venous Catheters Port a Catch
NCT03801811
Effectiveness of Cyanoacrylate Glue in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients: Randomised Clinical Trial (CIANO-ETI)
NCT05299060
Cyanoacrylate Closure for Treatment of Venous Leg Ulcers
NCT04011371
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Included patients
All patients referred to our hospital and treated by TAE with NBCA, based on clinical decisions in emergency and CT scan.
Clinical data
Collecting data from the medical record.
Imaging data
Collecting data from the medical record.
Biological data
Collecting data from the medical record.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical data
Collecting data from the medical record.
Imaging data
Collecting data from the medical record.
Biological data
Collecting data from the medical record.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rémi GRANGE, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de Saint-Etienne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Saint-Etienne
Saint-Priest-en-Jarez, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRBN042024/CHUSTE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.